DISCOUNT ZERTIFIKAT - BIOGEN IDEC | Delayed Deutsche Boerse AG 18:43:01 31/05/2024 BST | ||
| 174.3 EUR | +0.08% |
|
| 1 month | -0.79% | ||
| 3 months | +1.95% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 31/05/24 | 174.3 | +0.08% |
| 30/05/24 | 174.2 | +0.05% |
| 29/05/24 | 174.1 | +0.24% |
| 28/05/24 | 173.7 | -0.12% |
| 27/05/24 | 173.9 | -0.02% |
Delayed Quote Deutsche Boerse AG
Last update May 31, 2024 at 06:43 pm
More quotesStatic data
| Product type | Discount Certificates |
|---|---|
| Buy / Sell | CALL |
| Underlying | BIOGEN INC. |
| Issuer | 
Vontobel
|
| WKN | VM5US6 |
| ISIN | DE000VM5US62 |
| Date issued | 22/11/2023 |
| Maturity | 21/06/2024 (19 Days) |
| Parity | 1 : 1 |
| Emission price | 166.2 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 175.7 € |
|---|---|
| Lowest since issue | 163 € |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
224.9
USD
Average target price
284.8
USD
Spread / Average Target
+26.60%
- Stock Market
- Certificates
- Certificat